Celldex Therapeutics
CLDX
CLDX
162 hedge funds and large institutions have $917M invested in Celldex Therapeutics in 2015 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 68 increasing their positions, 40 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding in top 10
Funds holding in top 10: →
53% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 43
58% less capital invested
Capital invested by funds: $2.18B → $917M (-$1.27B)
Holders
162
Holding in Top 10
1
Calls
$9.58M
Puts
$17.5M
Top Buyers
| 1 | +$20.2M | |
| 2 | +$10.6M | |
| 3 | +$6.3M | |
| 4 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$5.46M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$4.93M |
Top Sellers
| 1 | -$47.3M | |
| 2 | -$19M | |
| 3 | -$15.1M | |
| 4 |
Bank of New York Mellon
New York
|
-$11.8M |
| 5 |
Axa
Paris,
France
|
-$9.65M |